Executive Director, INT Oncology Marketing
Moderna
Summary
This individual contributor role will be central to shaping the commercial future of Moderna's oncology portfolio as we advance intismeran autogene in collaboration with Merck. You will help prepare for Moderna's first commercial therapeutic launch in oncology, building strategy across marketed and potential indications in the US and EX-US while helping establish the foundations of Moderna's oncology business. Reporting to the Vice President of Oncology Marketing, you will combine enterprise-level strategic leadership with hands-on execution, translating first-of-its-kind personalized cancer science into clear commercial choices and executable go-to-market strategies.
Job description
Here's What You'll Do
- Own the development of brand positioning, messaging, and competitive strategy for all lifecycle indications, helping establish a differentiated commercial narrative for intismeran autogene and its potential role across diverse tumor types.
- Shape and actualize the US and EX-US commercial strategy for the intismeran portfolio across marketed and potential indications, leading strategy for all indications outside adjuvant melanoma in close collaboration with our alliance partner.
- Oversee customer and market insight generation with our alliance partner through primary and secondary market research, competitive intelligence, advisory boards, and other sources of evidence that inform strategic decision-making.
- Establish a multi-year strategic roadmap spanning marketed products and pipeline indications, ensuring lifecycle opportunities are translated into sequenced commercial priorities and clear execution plans.
- Lead scenario planning, risk management, and contingency strategy for future launches, including the integration of commercial forecasting and supply chain coordination.
- Shape prioritization, resource allocation, and investment planning across future commercial opportunities, bringing a business owner's mindset to decisions supporting the growth of a potential blockbuster brand based on first-of-its-kind technology and science.
- Translate commercial strategy, evolving product profiles, clinical evidence, and Moderna's scientific platforms into clear, actionable, and easily executable go-to-market strategies.
- Lead select strategic initiatives across the brand in both the US and EX-US, operating with the dynamic range to move seamlessly between long-term strategy development and detailed execution.
- Partner closely with Sales, Commercial Operations, Clinical Development, Medical Affairs, Market Access and Value Creation, Finance, Regulatory, Legal, and other critical members of the oncology ecosystem, including our alliance partner, to deliver against the ambition for the brand.
- Identify capability-development opportunities within Sales and the broader commercial organization and develop the tools, resources, and approaches required to strengthen team skills and readiness for future indications and launches.
- Help build the commercial foundations required for Moderna's expansion into cancer therapeutics, contributing to the launch of a pioneering personalized mRNA oncology program designed around each patient's unique tumor profile.
- Bring a highly collaborative, roll-your-sleeves-up leadership style suited to a rapidly growing biotech environment, balancing high-visibility strategic leadership with direct ownership of critical work.
- Explore opportunities to use Generative AI and other emerging digital tools to accelerate insight synthesis, scenario development, competitive assessment, content development, and commercial decision-making, while operating within appropriate governance and compliance frameworks.
Here's What You'll Need (Basic Qualifications)
- Bachelor's degree required
- Minimum of 12+ years of progressive marketing experience within the biopharmaceutical or biotech industry
- Proven leadership of multiple oncology brands or franchises with significant US Oncology commercialization experience
- Experience launching brands outside the US
- Demonstrated strong presentation, communication, collaboration, and stakeholder management skills
- Ability to travel 20%+
Here's What You'll Bring to the Table (Preferred Qualifications)
- Oncology launch experience required, particularly recent experience in the US or Global markets
- Master's degree in associated business or science degrees a plus
- Experience executing in an alliance relationship
- Melanoma or NSCLC experience strongly preferred
- Experience working in a solution oriented, dynamic, startup environment
- Strong adaptability with an ownership mindset working in a highly dynamic environment
Requirements
- Bachelor's degree required
- Minimum of 12+ years of progressive marketing experience within the biopharmaceutical or biotech industry
- Proven leadership of multiple oncology brands or franchises with significant US Oncology commercialization experience
- Experience launching brands outside the US
- Demonstrated strong presentation, communication, collaboration, and stakeholder management skills
- Ability to travel 20%+
- Oncology launch experience required, particularly recent experience in the US or Global markets
- Master's degree in associated business or science degrees a plus
- Experience executing in an alliance relationship
- Melanoma or NSCLC experience strongly preferred
- Experience working in a solution oriented, dynamic, startup environment
- Strong adaptability with an ownership mindset working in a highly dynamic environment
Benefits
- Competitive healthcare
- Voluntary benefit programs
- Fitness support
- Mindfulness support
- Mental health support
- Family planning benefits
- Fertility support
- Adoption support
- Surrogacy support
- Paid time off
- Vacation
- Volunteer days
- Sabbatical
- Global recharge days
- Year-end shutdown
- Savings and investments
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.